机译:小儿肝移植后肾小球滤过率的经验
Cincinnati Children's Hospital Medical Center, Cincinnati, OH;
The Hospital for Sick Children, Toronto, Canada;
CHU Sainte-Justine, Montreal, Canada;
University of Michigan Health System, Ann Arbor, MI;
Cincinnati Children's Hospital Medical Center, Cincinnati, OH;
The EMMES Corporation, Rockville, MD Supported by National Institutes of Health (U01 DK061693-01A1). Additional support provided by Astellas Pharma US, Inc, and Roche Laboratories.;
The EMMES Corporation, Rockville, MD Supported by National Institutes of Health (U01 DK061693-01A1). Additional support provided by Astellas Pharma US, Inc, and Roche Laboratories.;
The EMMES Corporation, Rockville, MD Supported by National Institutes of Health (U01 DK061693-01A1). Additional support provided by Astellas Pharma US, Inc, and Roche Laboratories.;
Cincinnati Children's Hospital Medical Center, Cincinnati, OH;
glomerular filtration rate; multicenter studies; pediatric liver transplantation; long-term outcomes; renal dysfunction;
机译:小儿肝移植后的肾小球滤过率-SPLIT经验。
机译:量身定制的肾小球滤过率预测公式,可早期检测小儿活体供体肝移植后肾功能的恶化
机译:环孢素和他克莫司对小儿原位后肝移植患者肾小球滤过率影响的比较。
机译:验证菲律宾儿科精确确定肾小球过滤速率的使用
机译:在实体器官移植受者中基于肌酐的肾小球滤过率估计方程的性能。
机译:肾脏疾病以外的肾小球滤过率估计值的波动改善了终末期肝病门诊患者和肾脏移植后结果的全球急性肾脏损伤诊断标准
机译:联合肝肾移植与肝脏移植单独基于估计肾小球过滤率的KDIGO分层:来自英国移植登记处的数据 - 回顾性队列研究